| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 505,843 | 500,757 | 497,946 | 486,928 | | Cost of Revenue | (770,873) | 385,020 | 385,853 | 390,036 | | | Gross Profit | 1,276,716 | 115,737 | 112,093 | 96,892 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,202,568 | 31,721 | 33,707 | 31,286 | | Non Recurring |
-
|
-
|
-
| 221,213 | | Others | 66,983 | 67,262 | 68,133 | 68,320 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,165 | 16,754 | 10,253 | (223,927) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 530 | (1,420) | 5,052 | 3,581 | | Earnings Before Interest And Taxes | 638 | 15,915 | 15,900 | (220,457) | | Interest Expense | 29,257 | 28,940 | 38,648 | 90,064 | | Income Before Tax | (28,619) | (13,025) | (22,748) | (310,521) | | Income Tax Expense | (7,329) | (2,495) | (9,112) | (31,735) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,990) | (10,530) | (13,636) | (278,786) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,290) | (10,530) | (13,636) | (278,786) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($21,290) | ($10,530) | ($13,636) | ($278,786) |
|
0.10% Nasdaq 0.00%
Income Statement
